Further optical imaging of mice bearing RFP-transgenic HT29 tumor xenografts verified that the combination therapy was superior to monotherapy of Ze-IR700-mediated PDT and RGR-TRAIL (Figure 6(C) and Supplementary Figure S8(B)). This evidence concerns the gene TNFSF10 and neoplasm.